ICYMI: 2021 #JITC Best Immune Cell Therapies and Immune Cell Engineering Award - "Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy" https://t.co/2oCnWz
$MDGEF $MDG1.DE $TSVT awarded at #SITC2021: Development of a #CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen #MAGE-A4 for next generation T-cell-based immunotherapy https://t.co/QXi9ispAai cc $blue $adap $regn
RT @jitcancer: New #JITC article: Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A…
RT @jitcancer: New #JITC article: Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A…
特异性针对肿瘤相关抗原MAGE-A4的CD8受体独立的T细胞受体的开发，用于下一代基于T细胞的免疫治疗 https://t.co/97luu39INR
$MDGEF $BLUE Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy https://t.co/QXi9ispAai cc $ADAP $IMTX $IMCR
New #JITC article: Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy https://t.co/UmROPO0buJ https://t.co/ActTSeKdgr